Login
From:
Drug Discovery and Development
(Uncensored)
subscribe
Eugenio De Corso on Dupixent for treating CRSwNP and asthma
https://www.drugdiscoverytrends.com/everest-lead-investigator-on-why-dupixent-sets-a-new-bar-for-treating-coexisting-crswnp-and-asthma/
links
backlinks
Tagged with:
clinical trials
immunology
biologics
pulmonology
The phase 4 EVEREST study showed that Dupixent demonstrated superiority over Xolair in adults with chronic rhinosinusitis.
Roast topics
Find topics
Find it!
